2008
DOI: 10.1016/j.vaccine.2008.03.041
|View full text |Cite
|
Sign up to set email alerts
|

Expression of VP1 protein in the milk of transgenic mice: A potential oral vaccine protects against enterovirus 71 infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
55
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 91 publications
(55 citation statements)
references
References 40 publications
0
55
0
Order By: Relevance
“…Recently, several new candidate EV71 vaccines were developed and provoked good immune responses against EV71 challenge in animals. 16,22,23,25,[34][35][36] However, given the potential safety, industrial and economic limitations of these vaccines, a safer, low priced and more effective EV71 vaccines need to be developed. 37 In this study, we produced the P1 protein in P. pastoris and evaluated its effects against EV71 infection by comparing the immune responses elicited by the purified P1 protein with those elicited by the heat-inactivated EV71 virus.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Recently, several new candidate EV71 vaccines were developed and provoked good immune responses against EV71 challenge in animals. 16,22,23,25,[34][35][36] However, given the potential safety, industrial and economic limitations of these vaccines, a safer, low priced and more effective EV71 vaccines need to be developed. 37 In this study, we produced the P1 protein in P. pastoris and evaluated its effects against EV71 infection by comparing the immune responses elicited by the purified P1 protein with those elicited by the heat-inactivated EV71 virus.…”
Section: Discussionmentioning
confidence: 99%
“…The difference between the protection of the anti-P1 serum (10 LD50, Table 2A and 2B) and the protection conferred from the vaccinating female (10000 LD50, Table 1A and Table 1B) suggests that the antibodies (SIgA) in the milk contributed to the protection against EV71 challenge in the offspring, which agreed with the previous reports. 22 It is understood that the protection in human babies conferred by breastfeeding was related to the levels of IgA(secretory IgA, sIgA) class enterovirus antibodies in breast milk, which seemed to be more important than transplacentally acquired antibodies. 38 In this study, the results of lethal EV71 challenge also showed that the mice pups can be protected from EV71 infection by it's mother, if the female mouse has been injected with the P1 protein or an inactivated EV71 vaccine.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…300μg of total RNA were used to isolate the poly(A + ) mRNA using the FastTrack ® MAG mRNA isolation kit (Invitrogen). An aliquot of 5 μl poly(A + ) mRNA was used for first-strand cDNA synthesis by SuperScript TM III reverse transcriptase (Gibco/BRL, Burlington, ON) as described [18]. A mature goat amelogenin cDNA fragment (0.7 kb) was amplified by PCR using a pair of primers, pAMEL-F (5'-CACTGAGAACGTGTGTTCAA AG-3') and pPolyT-R (5'-TTTTTTTTTTTTTTTTTTTGTA-3').…”
Section: A Cdna Cloning Of Goat Amelogenin Genesmentioning
confidence: 99%
“…In another study, a capsid protein from enterovirus 71 was produced in transgenic mice, and the milk, when given to mice orally, induced antibodies with antiviral effect and provided significant protection against virus infection. 37 Stowers et al have investigated the possibility of using this system for the production of malaria vaccine antigens. 38 In that study, two forms of MSP1 42 , either glycosylated or non-glycosylated, were produced in the milk of transgenic mice, at levels of 1.6 g/liter and 0.9 g/liter of purified antigen respectively.…”
mentioning
confidence: 99%